Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,372.00    -66.00 (-2.71%)
Bid:
2,372.00
Ask:
2,376.00
Spread: 4.00 (0.169%)
Market Cap: £6.16b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Directorate change

2 Apr 2026 07:00

RNS Number : 1594Z
Weir Group PLC
02 April 2026
 

 Press Release 2 April 2026

 

Changes to Board of Directors

The Weir Group PLC ("Weir") announces that Ravi Gopinath is appointed to the Board as an independent Non-Executive Director with effect from the conclusion of the AGM, on Thursday, 30 April 2026. Ravi will join the Audit, and Safety, Sustainability and Technology Committees upon appointment.

Ravi has held several senior leadership roles in industrial software and technology businesses. Most recently, he was Chief Product and Strategy Officer at AVEVA, the UK‑listed industrial software company, having previously served as Chief Operating Officer. Ravi was also Executive Vice President of Software at Schneider Electric. Earlier in his career, Ravi held senior executive positions at Invensys, including President of the Software Business, and was previously Chief Executive Officer of Geometric Limited. Ravi has also held a number of non‑executive director roles, including at the former FTSE 100 company Spectris plc. He is currently a non‑executive director of Thermax Limited and Neuland Laboratories, both of which are listed in India.

Weir also announces that Tracey Kerr will become a member of the Nomination Committee and Andy Agg will step down from the Nomination Committee, with effect from the conclusion of the AGM on 30 April 2026.

Commenting, Barbara Jeremiah, Chair of The Weir Group PLC said:

"On behalf of the Board, I am delighted to welcome Ravi to Weir. His extensive experience in senior roles within industrial software and technology businesses and knowledge of the importance of deeply understanding underlying customer needs combined with his international perspective, will be a significant asset to the Board. Ravi will bring valuable insight and expertise as we continue to execute our growth strategy across Weir."

Board Committee composition

Following Ravi's appointment, the Board Committee membership from the conclusion of the AGM on 30 April 2026 will be as follows:

Audit Committee

· Andy Agg (Committee Chair)

· Nick Anderson

· Penny Freer

· Tracey Kerr

· Ravi Gopinath

Nomination Committee

· Barbara Jeremiah (Board Chair and Committee Chair)

· Tracey Kerr

· Nick Anderson

· Dame Nicola Brewer

Remuneration Committee

· Penny Freer (Committee Chair)

· Nick Anderson

· Dame Nicola Brewer

· Ben Magara

Safety, Sustainability & Technology Committee

· Tracey Kerr (Committee Chair)

· Andy Agg

· Dame Nicola Brewer

· Ben Magara

· Ravi Gopinath

 

At the date of this announcement, Ravi Gopinath is a non‑executive director of Thermax Limited and Neuland Laboratories. He does not hold any shares in the Company. There are no other matters that require disclosure in accordance with the UK Listing Rules.

Jennifer HaddoukCompany Secretary

About The Weir Group PLC

Founded in 1871, The Weir Group PLC is one of the world's leading engineering businesses with a purpose to make its mining and infrastructure customers' operations more sustainable and efficient. Weir's highly engineered technology and digital solutions enable critical resources to be produced using less energy, water and waste while reducing customers' total cost of ownership. The Group is ideally positioned to benefit from structural trends that support long-term demand for its technology including the need for more essential metals to support economic development and carbon transition. The Group has c.12,000 employees operating in over 50 countries with a presence in every major mining region of the world. Find out more at www.global.weir.

 

Weir's ordinary shares trade on the London Stock Exchange (ticker: WEIR LN) and its American Depositary Receipts trade over-the-counter in the USA (ticker: WEGRY).

 

Enquiries:

Investors: Philip Carlisle

+44 (0)141 308 3617

Media: Sally Jones

+44 (0)141 308 3666

CDR: Claire de Groot

 

+44 (0) 207 638 9571

weir@cdrconsultancy.com

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKDBKBBKBKQK
Date   Source Headline
1st Jun 20262:45 pmRNSDirector/PDMR Shareholding
15th May 20269:16 amRNSHolding(s) in Company
13th May 20268:47 amRNSHolding(s) in Company
11th May 20269:50 amRNSDirector/PDMR Shareholding
8th May 20261:06 pmRNSDirector/PDMR Shareholding
8th May 20268:23 amRNSHolding(s) in Company
30th Apr 20264:24 pmRNSResult of AGM
30th Apr 20267:01 amRNSCEO Succession Announcement
30th Apr 20267:00 amRNSQ1 Trading Update
21st Apr 20262:20 pmRNSDirector/PDMR Shareholding
21st Apr 20262:16 pmRNSDirector/PDMR Shareholding
21st Apr 20262:14 pmRNSDirector/PDMR Shareholding
15th Apr 20264:17 pmRNSDirector/PDMR Shareholding
14th Apr 20262:49 pmRNSDirector/PDMR Shareholding
14th Apr 20262:48 pmRNSDirector/PDMR Shareholding
13th Apr 20267:00 amRNSHolding(s) in Company
9th Apr 202610:37 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirectorate change
31st Mar 20264:10 pmRNSDirector/PDMR Shareholding
26th Mar 20267:34 amRNSHolding(s) in Company
23rd Mar 202612:06 pmRNS2025 Annual Report and 2026 Annual General Meeting
10th Mar 20269:57 amRNSDirector Declaration
6th Mar 20267:56 amRNSHolding(s) in Company
4th Mar 20262:01 pmRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSFinal Results
3rd Mar 20267:00 amRNSWeir completes acquisition of ESEL
2nd Mar 20266:23 pmRNSHolding(s) in Company
16th Feb 20263:53 pmRNSHolding(s) in Company
30th Jan 20262:58 pmRNSHolding(s) in Company
26th Jan 202610:00 amRNS-RWeir receives 'A' score from CDP
14th Jan 20263:26 pmRNS-RWeir and Olayan announce key milestone
15th Dec 20258:36 amRNSDirectorate change
12th Dec 202510:30 amRNSWeir to acquire ESEL
4th Dec 20258:49 amRNSDirector Declaration
3rd Dec 20257:00 amRNSWeir Capital Markets Event
19th Nov 202510:02 amRNSDirector Declaration
11th Nov 20257:00 amRNSWeir completes acquisition of Fast2Mine
5th Nov 202512:20 pmRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSQ3 Trading Update
16th Oct 20251:48 pmRNSNotification of Change in Director’s Details
16th Oct 202512:00 pmRNSWeir AUD 400m Bond Pricing
23rd Sep 202512:00 pmRNSWeir to acquire Fast2Mine
22nd Sep 20254:05 pmRNSHolding(s) in Company
22nd Sep 20259:08 amRNSHolding(s) in Company
28th Aug 20255:56 pmRNSDirector/PDMR Shareholding
28th Aug 20255:39 pmRNSWeir completes acquisition of Townley
5th Aug 20253:42 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNSHalf-year Report
23rd Jul 20257:00 amRNS-RWeir retains CDP A score for climate transparency
30th Jun 202511:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.